Cardiovascular protection by SGLT2 inhibitors: an integrative review of mechanistic networks, clinical evidence, and safety considerations - Poll - MDSpire

Cardiovascular protection by SGLT2 inhibitors: an integrative review of mechanistic networks, clinical evidence, and safety considerations

  • By

  • Ziyun Wang

  • Yijin Wang

  • Wangning Shangguan

  • Tao Li

  • June 9, 2026

  • 0 min

Share

Original Source(s)

Related Content